Abcalis Multiclonal Recombinant Secondary Antibodies

Wednesday, 10 August, 2022 | Supplied by: Sapphire Bioscience


Multiclonals are recombinant secondary antibodies developed by AdipoGen’s innovative partner Abcalis. They consist of defined mixtures of carefully selected individual recombinant monoclonal antibodies, recognising different epitopes on all four different subclasses of human IgG. Their respective epitope binding sites do not compete with each other, therefore amplifying signal strengths.

Multiclonals are useful for secondary antibody applications where a polyclonal antibody would traditionally be used and are able to provide the specificity and reproducibility only available from a recombinant antibody, making them a suitable alternative for diagnostic and research applications.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Lumiprobe DusQ fluorescence quenchers

Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...

Enzo Life Sciences SCREEN-WELL Epigenetics library

Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...

LSBio PathPlus Cancer Antibodies

The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd